Cargando…
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
The widespread use of trastuzumab in the past decade has led to a significant and measureable improvement in the survival of patients with human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer, and in many ways has redefined the natural history of this aggressive breast cancer...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528960/ https://www.ncbi.nlm.nih.gov/pubmed/23143215 http://dx.doi.org/10.1007/s10549-012-2328-6 |